RADIOPHARMACEUTICAL PREPARATION "ASTAT-211" FOR TREATMENT OF ONCOLOGICAL DISEASE OF THYROID

medicine, oncology, radiology, pharmacy. SUBSTANCE: invention relates to a radiopharmaceutical preparation used for treatment of thyroid oncological diseases. The preparation comprises short-lived alpha- emitter isotope astatine-211 in an isotonic solution containing sodium chloride, sodium thiosulf...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	TULTAEV A.V, KIZHAEV E.V, ALIEV R.A, PLATONOV S.JU, JUMINOV O.A, FOTINA O.V, EREMENKO D.O
Format:	Patent
Sprache:	eng ; rus
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	medicine, oncology, radiology, pharmacy. SUBSTANCE: invention relates to a radiopharmaceutical preparation used for treatment of thyroid oncological diseases. The preparation comprises short-lived alpha- emitter isotope astatine-211 in an isotonic solution containing sodium chloride, sodium thiosulfate and sodium ortho-phosphate. Invention provides the significant decrease of radiation loading on patient body, to solve the problem of radiation safety of attendants and environment without using special measurements and to achieve the therapeutic effect under conditions of tissue hypoxia. EFFECT: enhanced effectiveness of preparation. 1 tbl